OTC nasal spray seemed to cut COVID infections by 67% in mid-sized trial

Health

Otc Nasal Spray Seemed To Cut Covid Infections By 67% In Mid-Sized Trial

By Ars Technica

Daily squirts of a safe, over-the-counter allergy nasal spray may prevent COVID-19 infections from taking hold, according to results published Tuesday in JAMA Internal Medicine. In a mid-staged trial, the spray appeared to reduce infections by promis ...Read more

Related Posts

Micah Parsons ‘wanted to be a Cowboy’, agent details in his view of contract negotiations

Micah Parsons ‘wanted to be a Cowboy’, agent details in his view of contract negotiations

Sep 02, 2025
California, Oregon and Washington ally on vaccines in rebuke to Trump’s CDC

California, Oregon and Washington ally on vaccines in rebuke to Trump’s CDC

Sep 03, 2025
Young children diagnosed with ADHD are often prescribed medication too quickly, study finds

Young children diagnosed with ADHD are often prescribed medication too quickly, study finds

Aug 29, 2025
Aid ship carrying Greta Thunberg, Susan Sarandon and other activists, set sail to Gaza

Aid ship carrying Greta Thunberg, Susan Sarandon and other activists, set sail to Gaza

Aug 31, 2025
We use cookies to help provide you with the best experience when you visit our websites. By using this site you consent to the use of cookies on your device. see our cookie policy.